Pleiotropic roles of AEG-1/MTDH/LYRIC in breast cancer

Advances in Cancer Research

Volumn 120, Issue , 2013, Pages 113-134

  Wan, Liling ^a   Kang, Yibin ^a,b  

^a PRINCETON UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

AEG 1; Breast cancer; Chemoresistance; Metadherin; Metastasis

Indexed keywords

PROTEIN AEG 1; PROTEIN LYRIC; PROTEIN METADHERIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER GROWTH; CHROMOSOME 8Q; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC GAIN; GENETIC VARIABILITY; HUMAN; METASTASIS; ONCOGENE; PATHOGENESIS; PLEIOTROPY; PRIORITY JOURNAL; TUMOR GROWTH;

AEG-1; BREAST CANCER; CHEMORESISTANCE; METADHERIN; METASTASIS;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION MOLECULES; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION;

EID: 84880960195     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-401676-7.00004-8     Document Type: Chapter

References (72)

1. Ash S.C., Yang D.Q., Britt D.E. LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochemical and Biophysical Research Communications 2008, 371:333-338.
2. Bergamaschi A., Kim Y.H., Wang P., Sorlie T., Hernandez-Boussard T., Lonning P.E., et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes, Chromosomes & Cancer 2006, 45:1033-1040.
3. Blanco M.A., Aleckovic M., Hua Y., Li T., Wei Y., Xu Z., et al. Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. The Journal of Biological Chemistry 2011, 286:19982-19992.
4. Britt D.E., Yang D.F., Yang D.Q., Flanagan D., Callanan H., Lim Y.P., et al. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Experimental Cell Research 2004, 300:134-148.
5. Brown D.M., Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004, 5:365-374.
6. Caudy A.A., Ketting R.F., Hammond S.M., Denli A.M., Bathoorn A.M., Tops B.B., et al. A micrococcal nuclease homologue in RNAi effector complexes. Nature 2003, 425:411-414.
7. Chen C.Z. MicroRNAs as oncogenes and tumor suppressors. The New England Journal of Medicine 2005, 353:1768-1771.
8. Chin L., Gray J.W. Translating insights from the cancer genome into clinical practice. Nature 2008, 452:553-563.
9. Dalgin G.S., Alexe G., Scanfeld D., Tamayo P., Mesirov J.P., Ganesan S., et al. Portraits of breast cancer progression. BMC Bioinformatics 2007, 8:291.
10. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
11. Emdad L., Lee S.G., Su Z.Z., Jeon H.Y., Boukerche H., Sarkar D., et al. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:21300-21305.
12. Emdad L., Sarkar D., Su Z.Z., Randolph A., Boukerche H., Valerie K., et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis. Cancer Research 2006, 66:1509-1516.
13. Gao X., Ge L., Shao J., Su C., Zhao H., Saarikettu J., et al. Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions. FEBS Letters 2010, 584:3525-3532.
14. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell 2011, 144:646-674.
15. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012, 31:3357-3369.
16. Hiscox S., Jiang W.G., Obermeier K., Taylor K., Morgan L., Burmi R., et al. Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. International Journal of Cancer 2006, 118:290-301.
17. Hu G., Chong R.A., Yang Q., Wei Y., Blanco M.A., Li F., et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009, 15:9-20.
18. Hu G., Wei Y., Kang Y. The multifaceted role of MTDH/AEG-1 in cancer progression. Clinical Cancer Research 2009, 15:5615-5620.
19. Hui A.B., Bruce J.P., Alajez N.M., Shi W., Yue S., Perez-Ordonez B., et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clinical Cancer Research 2011, 17:7539-7550.
20. Iorio M.V., Ferracin M., Liu C.G., Veronese A., Spizzo R., Sabbioni S., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Research 2005, 65:7065-7070.
21. Jeon H.Y., Choi M., Howlett E.L., Vozhilla N., Yoo B.K., Lloyd J.A., et al. Expression patterns of astrocyte elevated gene-1 (AEG-1) during development of the mouse embryo. Gene Expression Patterns 2010, 10:361-367.
22. Kang D.C., Su Z.Z., Sarkar D., Emdad L., Volsky D.J., Fisher P.B. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005, 353:8-15.
23. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007, 26:7647-7655.
24. Kim M.R., Choi H.K., Cho K.B., Kim H.S., Kang K.W. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells. Cancer Science 2009, 100:1834-1841.
25. Lee S.G., Jeon H.Y., Su Z.Z., Richards J.E., Vozhilla N., Sarkar D., et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009, 28:2476-2484.
26. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Fisher P.B. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17390-17395.
27. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Franke T.F., Fisher P.B. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008, 27:1114-1121.
28. Leverson J.D., Koskinen P.J., Orrico F.C., Rainio E.M., Jalkanen K.J., Dash A.B., et al. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Molecular Cell 1998, 2:417-425.
29. Li X., Kong X., Huo Q., Guo H., Yan S., Yuan C., et al. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Science 2011, 102:1151-1157.
30. Li C., Li Y., Wang X., Wang Z., Cai J., Wang L., et al. Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma. Histopathology 2012, 60:953-963.
31. Li C.L., Yang W.Z., Chen Y.P., Yuan H.S. Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing. Nucleic Acids Research 2008, 36:3579-3589.
32. Li J., Yang L., Song L., Xiong H., Wang L., Yan X., et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 2009, 28:3188-3196.
33. Li J., Zhang N., Song L.B., Liao W.T., Jiang L.L., Gong L.Y., et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clinical Cancer Research 2008, 14:3319-3326.
34. Li Y., Zou L., Li Q., Haibe-Kains B., Tian R., Desmedt C., et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nature Medicine 2010, 16:214-218.
35. Liu H., Song X., Liu C., Xie L., Wei L., Sun R. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. Journal of Experimental & Clinical Cancer Research 2009, 28:19.
36. Liu L., Wu J., Ying Z., Chen B., Han A., Liang Y., et al. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Research 2010, 70:3750-3759.
37. Liu X., Zhang N., Li X., Moran M.S., Yuan C., Yan S., et al. Identification of novel variants of metadherin in breast cancer. PLoS One 2011, 6:e17582.
38. McShea A., Samuel T., Eppel J.T., Galloway D.A., Funk J.O. Identification of CIP-1-associated regulator of cyclin B (CARB), a novel p21-binding protein acting in the G2 phase of the cell cycle. The Journal of Biological Chemistry 2000, 275:23181-23186.
39. Meng X., Brachova P., Yang S., Xiong Z., Zhang Y., Thiel K.W., et al. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. PLoS One 2011, 6:e20920.
40. Meng X., Liu J., Shen Z. Inhibition of G1 to S cell cycle progression by BCCIP beta. Cell Cycle 2004, 3:343-348.
41. Meng X., Lu H., Shen Z. BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1. Cell Cycle 2004, 3:1457-1462.
42. Meng X., Zhu D., Yang S., Wang X., Xiong Z., Zhang Y., et al. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. The Journal of Biological Chemistry 2012, 287:4485-4491.
43. Musgrove E.A., Sutherland R.L. Biological determinants of endocrine resistance in breast cancer. Nature Reviews. Cancer 2009, 9:631-643.
44. Nieto M.A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annual Review of Cell and Developmental Biology 2011, 27:347-376.
45. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Sakurai D., Fujimura L., et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). Journal of Human Genetics 2011, 56:595-601.
46. Orr N., Chanock S. Common genetic variation and human disease. Advances in Genetics 2008, 62:1-32.
47. Paukku K., Yang J., Silvennoinen O. Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5. Molecular Endocrinology 2003, 17:1805-1814.
48. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
49. Qian B.J., Yan F., Li N., Liu Q.L., Lin Y.H., Liu C.M., et al. MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer. Cancer Immunology, Immunotherapy 2011, 60:883-893.
50. Rice J., Ottensmeier C.H., Stevenson F.K. DNA vaccines: Precision tools for activating effective immunity against cancer. Nature Reviews. Cancer 2008, 8:108-120.
51. Sarkar D., Park E.S., Emdad L., Lee S.G., Su Z.Z., Fisher P.B. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Research 2008, 68:1478-1484.
52. Shaw N., Zhao M., Cheng C., Xu H., Saarikettu J., Li Y., et al. The multifunctional human p100 protein 'hooks' methylated ligands. Nature Structural & Molecular Biology 2007, 14:779-784.
53. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:10869-10874.
54. Su Z.Z., Kang D.C., Chen Y., Pekarskaya O., Chao W., Volsky D.J., et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 2002, 21:3592-3602.
55. Su P., Zhang Q., Yang Q. Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue. Diagnostic Pathology 2010, 5:38.
56. Sundstrom J.F., Vaculova A., Smertenko A.P., Savenkov E.I., Golovko A., Minina E., et al. Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome. Nature Cell Biology 2009, 11:1347-1354.
57. Sutherland H.G., Lam Y.W., Briers S., Lamond A.I., Bickmore W.A. 3D3/lyric: A novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Experimental Cell Research 2004, 294:94-105.
58. Thirkettle H.J., Girling J., Warren A.Y., Mills I.G., Sahadevan K., Leung H., et al. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clinical Cancer Research 2009, 15:3003-3013.
59. Thirkettle H.J., Mills I.G., Whitaker H.C., Neal D.E. Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 2009, 28:3663-3670.
60. Tokunaga E., Nakashima Y., Yamashita N., Hisamatsu Y., Okada S., Akiyoshi S., et al. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer 2012, 10.1007/s12282-012-0398-2.
61. Tong X., Drapkin R., Yalamanchili R., Mosialos G., Kieff E. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Molecular and Cellular Biology 1995, 15:4735-4744.
62. Wang S., Shu J.Z., Cai Y., Bao Z., Liang Q.M. Establishment and characterization of MTDH knockdown by artificial MicroRNA interference-Functions as a potential tumor suppressor in breast cancer. Asian Pacific Journal of Cancer Prevention 2012, 13:2813-2818.
63. Ward A., Balwierz A., Zhang J.D., Kublbeck M., Pawitan Y., Hielscher T., et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 2013, 32:1173-1182.
64. Yang J., Aittomaki S., Pesu M., Carter K., Saarinen J., Kalkkinen N., et al. Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. The EMBO Journal 2002, 21:4950-4958.
65. Yang J., Valineva T., Hong J., Bu T., Yao Z., Jensen O.N., et al. Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome. Nucleic Acids Research 2007, 35:4485-4494.
66. Yoo B.K., Chen D., Su Z.Z., Gredler R., Yoo J., Shah K., et al. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. Cancer Research 2010, 70:3249-3258.
67. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. The Journal of Clinical Investigation 2009, 119:465-477.
68. Yoo B.K., Gredler R., Vozhilla N., Su Z.Z., Chen D., Forcier T., et al. Identification of genes conferring resistance to 5-fluorouracil. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:12938-12943.
69. Yoo B.K., Santhekadur P.K., Gredler R., Chen D., Emdad L., Bhutia S., et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 2011, 53:1538-1548.
70. Yu C., Chen K., Zheng H., Guo X., Jia W., Li M., et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009, 30:894-901.
71. Yuan C., Li X., Yan S., Yang Q., Liu X., Kong B. The MTDH (-470G>A) polymorphism is associated with ovarian cancer susceptibility. PLoS One 2012, 7:e51561.
72. Zhang B., Liu X.X., He J.R., Zhou C.X., Guo M., He M., et al. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 2011, 32:2-9.